Current standard and future perspectives in first- and second-line treatment of metastatic pancreatic Adenocarcinoma
Wissenschaftlicher Artikel
Published in
Digestion ; 94 (2016), 1. - S. 44-49. - ISSN 0012-2823. - eISSN 1421-9867
Link to original publication
https://dx.doi.org/10.1159/000447739Institutions
UKU. Klinik für Innere Medizin IExternal cooperations
Georg-August-Universität GöttingenDocument version
published version (publisher's PDF)Subject headings
[GND]: Bauchspeicheldrüsenkrebs | Chemotherapie[MeSH]: Pancreatic neoplasms | Drug therapy
[Free subject headings]: Pancreatic cancer | Chemotherapy | Palliation
[DDC subject group]: DDC 610 / Medicine & health
Rights notice
Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich. This publication is with permission of the rights owner freely accessible due to an Alliance licence and a national licence (funded by the DFG, German Research Foundation) respectively.
Metadata
Show full item recordDOI & citation
Please use this identifier to cite or link to this item: http://dx.doi.org/10.18725/OPARU-39607
Ellenrieder, Volker; König, Alexander; Seufferlein, Thomas (2021): Current standard and future perspectives in first- and second-line treatment of metastatic pancreatic Adenocarcinoma. Open Access Repositorium der Universität Ulm und Technischen Hochschule Ulm. http://dx.doi.org/10.18725/OPARU-39607
Citation formatter >